Enhanced sonographic imaging to diagnose lymph node metastasis: Importance of blood vessel volume and density

Cancer Research

Volumn 73, Issue 7, 2013, Pages 2082-2092

  Li, Li ^a,b,c   Mori, Shiro ^c   Kodama, Mizuho ^c   Sakamoto, Maya ^a   Takahashi, Shoki ^b,c   Kodama, Tetsuya ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PERFLUBUTANE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXILLARY LYMPH NODE; BIOLUMINESCENCE; BLOOD VESSEL DIAMETER; CAPILLARY DENSITY; CELL PROLIFERATION; CONTRAST ENHANCED HIGH FREQUENCY ULTRASOUND; CONTRAST ENHANCEMENT; CONTROLLED STUDY; IMAGING SYSTEM; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LYMPH NODE; LYMPH NODE METASTASIS; LYMPH VESSEL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR CELL; ULTRASOUND SCANNER;

ANIMALS; AXILLA; BLOOD VESSELS; BLOOD VOLUME; FEMALE; HISTIOCYTOMA, MALIGNANT FIBROUS; IMMUNOENZYME TECHNIQUES; LYMPH NODES; LYMPHATIC DISEASES; LYMPHATIC METASTASIS; MICE; SENTINEL LYMPH NODE BIOPSY;

EID: 84876006169     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-4200     Document Type: Article

References (50)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100: 57-70.
2. Swartz MA, Lund AW. Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity. Nat Rev Cancer 2012;12:210-9.
3. Jain R, Dandekar P, Patravale V. Diagnostic nanocarriers for sentinel lymph node imaging. J Control Release 2009;138:90-102.
4. Jaffer FA, Weissleder R. Molecular imaging in the clinical arena. JAMA 2005;293:855-62.
5. Sever AR, Mills P, Jones SE, Cox K, Weeks J, Fish D, et al. Preoperative sentinel node identification with ultrasound using microbubbles in patients with breast cancer. AJR Am J Roentgenol 2011;196:251-6.
6. Yoon JH, Kim JY, Moon HJ, Youk JH, Son EJ, Kim EK, et al. Contribution of computed tomography to ultrasound in predicting lateral lymph node metastasis in patients with papillary thyroid carcinoma. Ann Surg Oncol 2011;18:1734-41.
7. Harnan SE, Cooper KL, Meng Y, Ward SE, Fitzgerald P, Papaioannou D, et al. Magnetic resonance for assessment of axillary lymph node status in early breast cancer: a systematic review and meta-analysis. Eur J Surg Oncol 2011;37:928-36.
8. Sironi S, Buda A, Picchio M, Perego P, Moreni R, Pellegrino A, et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology 2006;238: 272-9.
9. Kim HY, Yi CA, Lee KS, Chung MJ, Kim YK, Choi BK, et al. Nodal metastasis in non-small cell lung cancer: accuracy of 3.0-T MR imaging. Radiology 2008;246:596-604.
10. Zhang F, Zhu L, Huang X, Niu G, Chen X. Differentiation of reactive and tumor metastatic lymph nodes with diffusion-weighted and SPIO-enhanced MRI. Mol Imaging Biol 2013;15:40-7.
11. Crippa F, Leutner M, Belli F, Gallino F, Greco M, Pilotti S, et al. Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma. J Nucl Med 2000;41:1491-4.
12. Sharan S, Grigg JR, Higgins RA. Nanophthalmos: ultrasound biomicroscopy and Pentacam assessment of angle structures before and after cataract surgery. J Cataract Refract Surg 2006;32:1052-5.
13. Giancarlo T, Palmieri A, Giacomarra V, Russolo M. Pre-operative evaluation of cervical adenopathies in tumours of the upper aerodigestive tract. Anticancer Res 1998;18:2805-9.
14. De Swarte M, Alexander K, Rannou B, D'Anjou MA, Blond L, Beauchamp G. Comparison of sonographic features of benign and neoplastic deep lymph nodes in dogs. Vet Radiol Ultrasound 2011;52: 451-6.
15. Esen G. Ultrasound of superficial lymph nodes. Eur J Radiol 2006; 58:345-59.
16. van den Brekel MW, Castelijns JA, Snow GB. The size of lymph nodes in the neck on sonograms as a radiologic criterion for metastasis: how reliable is it? AJNR Am J Neuroradiol 1998;19:695-700.
17. Ying M, Ahuja A, Brook F. Accuracy of sonographic vascular features in differentiating different causes of cervical lymphadenopathy. Ultrasound Med Biol 2004;30:441-7.
18. Kagawa T, Yuasa K, Fukunari F, Shiraishi T, Miwa K. Quantitative evaluation of vascularity within cervical lymph nodes using Doppler ultrasound in patients with oral cancer: relation to lymph node size. Dentomaxillofac Radiol 2011;40:415-21.
19. Sibon C, Chagnon S, Tchakerian A, Bafounta ML, Longvert C, Clerici T, et al. The contribution of high-resolution ultrasonography in preoperatively detecting sentinel-node metastases in melanoma patients. Melanoma Res 2007;17:233-7.
20. Hinz T, Wilsmann-Theis D, Buchner A, Wenzel J, Wendtner CM, Bieber T, et al. High-resolution ultrasound combined with power Doppler sonography can reduce the number of sentinel lymph node biopsies in cutaneous melanoma. Dermatology 2011;222:180-8.
21. Servais EL, Colovos C, Bograd AJ, White J, Sadelain M, Adusumilli PS. Animal models and molecular imaging tools to investigate lymph node metastases. J Mol Med (Berl) 2011;89:753-69.
22. Li L, Mori S, Sakamoto M, Takahashi S, Kodama T. Mouse model of lymph node metastasis via afferent lymphatic vessels for development of imaging modalities. PLoS one. 2013;8:e55797.
23. Van den Broeck W, Derore A, Simoens P. Anatomy and nomenclature of murine lymph nodes: descriptive study and nomenclatory standardization in BALB/cAnNCrl mice. J Immunol Methods 2006;312: 12-9.
24. Ito MR, Terasaki S, Itoh J, Katoh H, Yonehara S, Nose M. Rheumatic diseases in an MRL strain of mice with a deficit in the functional Fas ligand. Arthritis Rheum 1997;40:1054-63.
25. Furukawa H, Kitazawa H, Kaneko I, Kikuchi K, Tohma S, Nose M, et al. Mast cells inhibit CD8+T cell-mediated rejection of a malignant fibrous histiocytoma-like tumor: involvement of Fas-Fas ligand axis. Am J Immunol 2009;5:89-97.
26. Murphy ED, Roths JB. Autoimmunity and lymphoproliferation: induction by mutant gene lpr, and acceleration by a male-associated factor in strain BXSB mice. In: Rose NR, Bigazzi PE, Warner LN, editors. Developments in immunology, vol. 1. New York: Elsevier/North-Holland; 1978. p. 207-21.
27. Dickson PV, Hamner B, Ng CY, Hall MM, Zhou J, Hargrove PW, et al. In vivo bioluminescence imaging for early detection and monitoring of disease progression in a murine model of neuroblastoma. J Pediatr Surg 2007;42:1172-9.
28. Sontum PC. Physicochemical characteristics of Sonazoid, a new contrast agent for ultrasound imaging. Ultrasound Med Biol 2008;34: 824-33.
29. de Jong JS, van Diest PJ, Baak JP. Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer. Histopathology 2000;36: 306-12.
30. Xuan JW, Bygrave M, Jiang H, Valiyeva F, Dunmore-Buyze J, Holdsworth DW, et al. Functional neoangiogenesis imaging of genetically engineered mouse prostate cancer using three-dimensional power Doppler ultrasound. Cancer Res 2007;67:2830-9.
31. Jugold M, Palmowski M, Huppert J, Woenne EC, Mueller MM, Semmler W, et al. Volumetric high-frequency Doppler ultrasound enables the assessment of early antiangiogenic therapy effects on tumor xenografts in nude mice. Eur Radiol 2008;18:753-8.
32. Furukawa MK, Furukawa M. Diagnosis of lymph node metastases of head and neck cancer and evaluation of effects of chemoradiotherapy using ultrasonography. Int J Clin Oncol 2010;15:23-32.
33. Catalano MF, Sivak MV Jr, Rice T, Gragg LA, Van Dam J. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc 1994;40:442-6.
34. Yoong KF, Afford SC, Randhawa S, Hubscher SG, Adams DH. Fas/Fas ligand interaction in human colorectal hepatic metastases: a mechanism of hepatocyte destruction to facilitate local tumor invasion. Am J Pathol 1999;154:693-703.
35. Gannon PO, Alam Fahmy M, Begin LR, Djoukhadjian A, Filali-Mouhim A, Lapointe R, et al. Presence of prostate cancer metastasis correlates with lower lymph node reactivity. Prostate 2006;66: 1710-20.
36. Zenk J, Bozzato A, Hornung J, Gottwald F, Rabe C, Gill S, et al. Neck lymph nodes: prediction by computer-assisted contrast medium analysis? Ultrasound Med Biol 2007;33:246-53.
37. Woolgar JA. Micrometastasis in oral/oropharyngeal squamous cell carcinoma: incidence, histopathological features and clinical implications. Br J Oral Maxillofac Surg 1999;37:181-6.
38. Moll R, Ramaswamy A. In: Werner JA, Davis RK, editors. Metastases in head and neck cancer. Berlin, Heidelberg, New York: Springer; 2004. Chapter 3, p. 70-2.
39. Kodama T, Tomita N, Yagishita Y, Horie S, Funamoto K, Hayase T, et al. Volumetric and angiogenic evaluation of antitumor effects with acoustic liposome and high-frequency ultrasound. Cancer Res 2011;71: 6957-64.
40. Pysz MA, Foygel K, Panje CM, Needles A, Tian L, Willmann JK. Assessment and monitoring tumor vascularity with contrast-enhanced ultrasound maximum intensity persistence imaging. Invest Radiol 2011;46:187-95.
41. Turkbey B, Kobayashi H, Ogawa M, Bernardo M, Choyke PL. Imaging of tumor angiogenesis: functional or targeted? AJR Am J Roentgenol 2009;193:304-13.
42. Economopoulos V, Noad JC, Krishnamoorthy S, Rutt BK, Foster PJ. Comparing the MRIappearance of thelymph nodes andspleen in wildtype and immuno-deficient mouse strains. PLoS ONE 2011;6:e27508.
43. Morse HC III, Davidson WF, Yetter RA, Murphy ED, Roths JB, Coffman RL. Abnormalities induced by the mutant gene Ipr: expansion of a unique lymphocyte subset. J Immunol 1982;129:2612-5.
44. Davidson WF, Dumont FJ, Bedigian HG, Fowlkes BJ, Morse HC III. Phenotypic, functional, and molecular genetic comparisons of the abnormal lymphoid cells of C3H-lpr/lpr and C3H-gld/gld mice. J Immunol 1986;136:4075-84.
45. Masuda A, Kasajima T. Follicular dendritic cell dysfunction and disorganization of lymphoid structures in MRL/lpr mice. Lab Invest 1999;79:849-57.
46. Hoshida T, Isaka N, Hagendoorn J, di Tomaso E, Chen YL, Pytowski B, et al. Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res 2006;66:8065-75.
47. Qiao J, Kottke T, Willmon C, Galivo F, Wongthida P, Diaz RM, et al. Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy. Nat Med 2008;14:37-44.
48. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002;2:573-83.
49. Bono P, Wasenius VM, Heikkila P, Lundin J, Jackson DG, Joensuu H. High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer. Clin Cancer Res 2004;10: 7144-9.
50. Mumprecht V, Honer M, Vigl B, Proulx ST, Trachsel E, Kaspar M, et al. In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography. Cancer Res 2010;70:8842-51.